Leiomyosarcoma — Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
Citation(s)
TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Leiomyosarcoma